HIS REPORTER DISPLACEMENT ASSAY FOR FRAGMENT SCREENING AND FRAGMENT EVOLUTION TOWARD LEADS WITH OPTIMIZED BINDING KINETICS, BINDING SELECTIVITY, AND THERMODYNAMIC SIGNATURE

被引:47
作者
Neumann, Lars [1 ]
von Koenig, Konstanze [1 ]
Ullmann, Dirk [1 ]
机构
[1] Proteros Biostruct GmbH, Martinsried, Germany
来源
FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES | 2011年 / 493卷
关键词
ACTIVATED PROTEIN-KINASE; RESIDENCE TIME; DRUG; TECHNOLOGY; DISCOVERY; BIOSENSOR; ENTHALPY; RECEPTOR; ENTROPY;
D O I
10.1016/B978-0-12-381274-2.00012-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Parameters such as residence time, kinetic selectivity, and thermodynamic signature are more and more under debate as optimization objectives within fragment-based lead discovery. However, broad implementation of these parameters is hampered by the lack of technologies that give rapid access to binding kinetics and thermodynamic information for large amounts of compound-target interactions. Here, the authors describe a technology the reporter displacement assay that is capable of opening this bottleneck and of supporting data-driven design of lead compounds with tailor-made residence time, kinetic selectivity, and thermodynamic signature.
引用
收藏
页码:299 / 320
页数:22
相关论文
共 28 条
[1]  
[Anonymous], CURR OPIN STRUCT BIO
[2]   Calorimetry and thermodynamics in drug design [J].
Chaires, Jonathan B. .
ANNUAL REVIEW OF BIOPHYSICS, 2008, 37 :135-151
[3]   DNA binding domain of RFX5: Interactions with X-box DNA and RFXANK [J].
Chakraborty, Madhumita ;
Sengupta, Amitava ;
Bhattacharya, Dipankar ;
Banerjee, Subrata ;
Chakrabarti, Abhijit .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (10) :2016-2024
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]   Opinion - Drug-target residence time and its implications for lead optimization [J].
Copeland, Robert A. ;
Pompliano, David L. ;
Meek, Thomas D. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :730-739
[6]   A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry [J].
Deinum, J ;
Gustavsson, L ;
Gyzander, E ;
Kullman-Magnusson, M ;
Edström, Å ;
Karlsson, R .
ANALYTICAL BIOCHEMISTRY, 2002, 300 (02) :152-162
[7]   Thermodynamics guided lead discovery and optimization [J].
Ferenczy, Gyoergy G. ;
Keserue, Gyoergy M. .
DRUG DISCOVERY TODAY, 2010, 15 (21-22) :919-932
[8]   Do enthalpy and entropy distinguish first in class from best in class? [J].
Freire, Ernesto .
DRUG DISCOVERY TODAY, 2008, 13 (19-20) :869-874
[9]   A Thermodynamic Approach to the Affinity Optimization of Drug Candidates [J].
Freire, Ernesto .
CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 74 (05) :468-472
[10]   Thermodynamics of aminoglycoside and acyl-coenzyme A binding to the Salmonella enterica AAC(6′)-Iy aminoglycoside N-acetyltransferase [J].
Hegde, SS ;
Dam, TK ;
Brewer, CF ;
Blanchard, JS .
BIOCHEMISTRY, 2002, 41 (23) :7519-7527